These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23165619)

  • 41. Adverse effects of irreversible electroporation of malignant liver tumors under CT fluoroscopic guidance: a single-center experience.
    Dollinger M; Beyer LP; Haimerl M; Niessen C; Jung EM; Zeman F; Stroszczynski C; Wiggermann P
    Diagn Interv Radiol; 2015; 21(6):471-5. PubMed ID: 26359870
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radiofrequency ablation: the experts weigh in.
    Tanabe KK; Curley SA; Dodd GD; Siperstein AE; Goldberg SN
    Cancer; 2004 Feb; 100(3):641-50. PubMed ID: 14745883
    [No Abstract]   [Full Text] [Related]  

  • 43. The truth about radiofrequency ablation and laparoscopic liver resection.
    Abdalla EK
    Ann Surg; 2011 Apr; 253(4):841-2; author reply 842-3. PubMed ID: 21475034
    [No Abstract]   [Full Text] [Related]  

  • 44. Colorectal liver metastases: making the unresectable resectable using irreversible electroporation for microscopic positive margins - a case report.
    Schoellhammer HF; Goldner B; Merchant SJ; Kessler J; Fong Y; Gagandeep S
    BMC Cancer; 2015 Apr; 15():271. PubMed ID: 25886376
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bile Duct Injury after Irreversible Electroporation of Hepatic Malignancies: Evaluation of MR Imaging Findings and Laboratory Values.
    Dollinger M; Zeman F; Niessen C; Lang SA; Beyer LP; Müller M; Stroszczynski C; Wiggermann P
    J Vasc Interv Radiol; 2016 Jan; 27(1):96-103. PubMed ID: 26777402
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins.
    Distelmaier M; Barabasch A; Heil P; Kraemer NA; Isfort P; Keil S; Kuhl CK; Bruners P
    Radiology; 2017 Dec; 285(3):1023-1031. PubMed ID: 28799842
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The efficacy and safety of irreversible electroporation for the ablation of renal masses: a prospective, human, in-vivo study protocol.
    Wagstaff PG; de Bruin DM; Zondervan PJ; Savci Heijink CD; Engelbrecht MR; van Delden OM; van Leeuwen TG; Wijkstra H; de la Rosette JJ; Laguna Pes MP
    BMC Cancer; 2015 Mar; 15():165. PubMed ID: 25886058
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Irreversible Electroporation: Defining the MRI Appearance of the Ablation Zone With Histopathologic Correlation in a Porcine Liver Model.
    Felker ER; Dregely I; Chung DJ; Sung K; Osuagwu FC; Lassman C; Sayre J; Wu H; Lu DS
    AJR Am J Roentgenol; 2017 May; 208(5):1141-1146. PubMed ID: 28177652
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pain After Percutaneous Irreversible Electroporation of Renal Tumors Is Not Dependent on Tumor Location.
    Sorokin I; Lay AH; Reddy NK; Canvasser NE; Chamarthy M; Cadeddu JA
    J Endourol; 2017 Aug; 31(8):751-755. PubMed ID: 28586250
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatocellular carcinoma: new options for image-guided ablation.
    Lencioni R; Cioni D; Della Pina C; Crocetti L
    J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):399-403. PubMed ID: 20091187
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transdiaphragmatic radiofrequency ablation of liver tumors.
    Mullen JT; Walsh GL; Abdalla EK; Loyer EM; Curley SA; Vauthey JN
    J Am Coll Surg; 2004 Nov; 199(5):826-9. PubMed ID: 15501127
    [No Abstract]   [Full Text] [Related]  

  • 52. Pain analysis in patients with hepatocellular carcinoma: irreversible electroporation versus radiofrequency ablation-initial observations.
    Narayanan G; Froud T; Lo K; Barbery KJ; Perez-Rojas E; Yrizarry J
    Cardiovasc Intervent Radiol; 2013 Feb; 36(1):176-82. PubMed ID: 22752100
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Irreversible Electroporation of Hepatic and Pancreatic Malignancies: Radiologic-Pathologic Correlation.
    Gonzalez-Beicos A; Venkat S; Songrug T; Poveda J; Garcia-Buitrago M; Poozhikunnath Mohan P; Narayanan G
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):176-82. PubMed ID: 26365548
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Irreversible electroporation ablation of malignant hepatic tumors: subacute and follow-up CT appearance of ablation zones.
    Dollinger M; Jung EM; Beyer L; Niessen C; Scheer F; Müller-Wille R; Stroszczynski C; Wiggermann P
    J Vasc Interv Radiol; 2014 Oct; 25(10):1589-94. PubMed ID: 25156648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radiofrequency ablation of liver and lung tumors.
    Waddle JA
    Radiol Technol; 2006; 78(1):45-55; quiz 56-8. PubMed ID: 16998194
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of approach on outcome in radiofrequency ablation of liver tumors.
    Burdio F; Mulier S; Navarro A; Figueras J; Berjano E; Poves I; Grande L
    Surg Oncol; 2008 Dec; 17(4):295-9. PubMed ID: 18472417
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-Frequency Irreversible Electroporation: Safety and Efficacy of Next-Generation Irreversible Electroporation Adjacent to Critical Hepatic Structures.
    Siddiqui IA; Kirks RC; Latouche EL; DeWitt MR; Swet JH; Baker EH; Vrochides D; Iannitti DA; Davalos RV; McKillop IH
    Surg Innov; 2017 Jun; 24(3):276-283. PubMed ID: 28492356
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Percutaneous treatment of extrahepatic recurrence of hepatocellular carcinoma.
    Doreille A; N'Kontchou G; Halimi A; Bouhafs F; Coderc E; Sellier N; Seror O
    Diagn Interv Imaging; 2016 Nov; 97(11):1117-1123. PubMed ID: 27138073
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radiofrequency ablation for liver tumors: going multipolar?
    Snoeren N; van Hillegersberg R
    Expert Rev Med Devices; 2011 Jan; 8(1):1-2. PubMed ID: 21158533
    [No Abstract]   [Full Text] [Related]  

  • 60. Ablative therapy of liver tumors.
    Hol PK
    Acta Radiol; 2007 Jun; 48(5):473. PubMed ID: 17520419
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.